Cell Impact AB (CI) — Strategic Asset Allocation Index
Cell Impact AB (CI) has a Strategic Asset Allocation Index of 68.1% as of June 2023. Strategic assets (PP&E of Skr180.61 Million plus long-term investments of Skr-) total Skr180.61 Million, measured against net assets of Skr265.32 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CI net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Cell Impact AB Strategic Asset Allocation Index (2019–2022)
This chart shows how Cell Impact AB's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 68.1%, representing strategic assets of Skr180.61 Million against net assets of Skr265.32 Million SEK. For live market cap and overall valuation, see CI market cap overview.
Annual Strategic Asset Allocation Index for Cell Impact AB (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Cell Impact AB from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CI net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 47.5% | Skr154.21 Million | Skr154.21 Million | Skr- | Skr324.35 Million | ▼ -26.4 pp |
| 2021 | 74.0% | Skr105.52 Million | Skr105.52 Million | Skr- | Skr142.62 Million | ▲ +44.1 pp |
| 2020 | 29.9% | Skr60.35 Million | Skr60.35 Million | Skr- | Skr201.89 Million | ▼ -30.0 pp |
| 2019 | 59.9% | Skr27.00 Million | Skr27.00 Million | Skr- | Skr45.05 Million | — |